Abstract Jun a 3, a major allergenic protein in mountain cedar pollen, causes seasonal allergic rhinitis in hypersensitive individuals.
Introduction
Type I hypersensitivity diseases afflict up to a quarter of the world's population. Inadequacies in current therapies are driving efforts to identify alternative sources for allergen vaccines, which might increase the effectiveness and reduce the adverse effects of this therapy (Breiteneder et al. 2001) . The use of recombinant allergens could allow modification of the expressed proteins to reduce reactogenecity, and thereby reduce the risk associated with injection of crude allergen extracts (Akdis and Blaser 2000; Valenta et al. 2002; Singh and Bhalla 2006) . Finally, recombinant allergens are valuable tools for structural analysis, including that of critical epitopes, and could provide a better understanding of the allergic immune response.
Protein expression systems for producing such allergens must consistently produce adequate amounts of recombinant allergens that retain the immunogenic nature of the native allergen. The yeast P. pastoris has been used to express many allergens (Barral et al. 2004; Saarelainen et al. 2004; Barderas et al. 2005) . Because P. pastoris secretes few of its own proteins, recombinant proteins extracted from the medium are less contaminated with endogenous proteins than those expressed intracellularly. Several recombinant allergens have also been produced in ground leaves of N. benthamiana plants via a tobacco mosaic virus (TMV) vector (Krebitz et al. 2000 (Krebitz et al. , 2003 . However, extraction from ground leaves can make purification difficult. This can be overcome by expressing the protein in the plant apoplast through the use of a signal peptide. The protein can be extracted from the apoplast by vacuum infiltration of the leaf. Upon centrifugation, the buffer will spin out of the leaf bringing the foreign protein along with it. This approach provides an initial purification step by eliminating most plant cellular proteins (McCormick et al. 1999) .
Previous attempts to express Jun a 3 allergen, a 30 kDa protein of Juniperus ashei trees, in bacteria were unsuccessful (Goetz et al. 1995; Midoro-Horiuti et al. 2000; Soman et al. 2000) . Here we describe the expression of recombinant Jun a 3 (rJun a 3) in Nicotiana benthamiana and in Pichia pastoris. The recombinant allergen bound polyclonal IgG antibodies raised against native Jun a 3, as well as IgE antibodies in the sera of subjects allergic to mountain cedar pollen. Furthermore, we have demonstrated for the first time that extraction of a recombinant allergen from the plant apoplast via vacuum infiltration is advantageous as an initial purification step, compared to secretion in P. pastoris.
Materials and methods

Isolation of Juniperus ashei RNA and cDNA synthesis
Juniperus ashei pollen was purchased from HollisterStier (Spokane, WA). Total RNA was isolated from 50 mg pollen using Promega's RNAgents Total RNA Isolation System. Reverse transcription of 2 lg mRNA was achieved using an oligo-dT primer and an M-MLV reverse transcriptase. Second-strand synthesis was accomplished via PCR using primers specific for the Jun a 3 sequence. The following primers were designed for TMV-plasmid cloning: 5 0 -GCGGTTAATTAAA TGGCCCGAGTATCAGAGCTTGCG-3 0 (sense, PacI restriction site in bold followed by Jun a 3 native signal peptide sequence) and 5 0 -GGCGCTCGAGTTAGGG ACAGAATACAATACT-3 0 (antisense, XhoI restriction site bold, stop codon underlined). Primers designed for yeast-plasmid cloning are as follows: 5 0 -GCGGCT CGAGAAAAGAGAGGCTGCCCGAGTATCAGAG CTTGC-3 0 (sense, XhoI restriction site bold, Kex2/ Ste13 cleavage sites underlined followed by Jun a 3 coding sequence) and 5 0 -GCGGGCGGCCGCTCAA GGGCAGAATACAATACTGT-3 0 (antisense, NotI restriction site bold, stop codon underlined).
Production of recombinant Jun a 3 in N. benthamiana Construction of the pBSG1057-Jun a 3 expression vector and inoculation of N. benthamiana plants with recombinant infectious RNA A 30B-based tobacco mosaic virus vector, pBSG1057, (Large Scale Biology Corporation, Vacaville, CA) and the Jun a 3 construct (containing its native signal peptide sequence) were digested with PacI and XhoI. Following ligation, the pBSG1057-Jun a 3 products were used to transform competent DH5a E. coli cells via electroporation. Positive clones were sequenced using a CEQ capillary sequencer (Beckman Coulter).
The pBSG1057-Jun a 3 vector was in vitro transcribed to generate capped infectious RNA using T7 RNA polymerase from the mMessage mMachine kit (Ambion). An equal volume of FES buffer (0.1 M glycine pH 8.9, 0.06 M K 2 HPO 4 , 1% sodium pyrophosphate, 1% Celite, 1% bentonite) was added to each reaction, and two N. benthamiana leaves were mechanically inoculated per plant (10 ll per leaf). Ten days post-inoculation, the virus was passaged to larger plants by grinding 1 g infected leaf material with 1 ml GP-Celite buffer (50 mM glycine pH 8.9, 30 mM K 2 HPO 4 , 1% w/v celite) and rubbing the inoculum onto two leaves per plant.
Detection of viral RNA and extraction of Jun a 3 protein
Fourteen days post-inoculation, total RNA was extracted from 100 mg systemically infected leaves using Qiagen's RNeasy Plant Mini Kit. The RNA was reverse transcribed using an oligo-dT primer. This served as a template for PCR, in which pBSG1057-specific primers that flanked the inserted gene were used. Twenty-one days post-inoculation, secreted proteins were extracted using a vacuum infiltration method (McCormick et al. 1999) . Specifically, 2 g leaf material was submerged in 50 ml infiltration buffer (100 mM Tris/HCl (pH 7.5), 10 mM MgCl 2 , 2 mM EDTA). This was placed into a vacuum chamber for 2 min. The vacuum was removed by allowing air to flow into the chamber as a sudden single burst, causing the leaves to turn darker in color and sink. The leaves were removed, dried with paper towels, and then placed into a strainer cup positioned into a 250 ml centrifuge tube. After centrifugation at 2,000g for 10 min (4°C), secreted proteins were collected from the bottom of the centrifuge tube.
Production of rJun a 3 in P. pastoris
Construction of the pPICZa-Jun a 3 expression plasmid
Restriction digests were performed on the pPICZa vector (Invitrogen) and the Jun a 3 PCR product using XhoI and NotI, followed by ligation. The pPICZa-Jun a 3 (pPICZa-J3) ligation products were transformed into competent DH5a E. coli cells according to company protocols (Invitrogen, Carlsbad, CA). Transformants were plated on low salt LB plates supplemented with Zeocin (25 lg/ml). PCR was used to select for clones containing the Jun a 3 insert. Positive clones were sequenced using a CEQ capillary sequencer (Beckman Coulter). Ten micrograms of pPICZa-J3 were completely linearized with SacI, and the purified fragments were used to electroporate P. pastoris cells, strain GS115, to allow a single crossover recombination event at the AOXI locus. Transformants were plated on yeast extract peptone dextrose sorbitol medium/Zeocin (100 lg/ml) and incubated at 30°C for 3 days. Colonies were then plated onto minimal methanol histidine (MMH) plates and incubated for 2 days at 30°C to select for the Mut + phenotype.
Expression of rJun a 3
Clones with the Mut + phenotype were inoculated into 50 ml of buffered glycerol complex medium in a 500 ml baffled flask and allowed to grow at 30°C with shaking at 250 rpm for approx 30 h, or until the OD 600 reached 2-6. The culture was then centrifuged, and the remaining cell pellet was resuspended in buffered methanol complex media to an OD 600 of 1 to induce expression. Cultures were shaken in 500 ml baffled flasks at 30°C for 96 h. Methanol was added daily to give 0.5%, and samples were taken daily to evaluate expression levels. Cells were cleared from the culture samples by centrifugation.
Immunoblotting experiments
Proteins were analyzed on 15% (v/v) polyacrylamide gels. Protein concentrations were determined by the Bradford method. N-Terminal sequencing was performed on the rJun a 3 protein using Applied Biosystem's Procise sequencing system (Biomedical Resources Laboratory at University of Texas Medical Branch at Galveston).
Proteins separated via SDS-PAGE were transferred to a PVDF membrane. The membranes were blocked and then incubated with rabbit polyclonal anti-Jun a 3 IgG antibody at 1 lg/ml. Bound IgG was detected with anti-rabbit IgG-HRP conjugate (1:1,000, Sigma). Visualization was performed using ECL TM detection reagents (Amersham) followed by immunofluorescence detection.
IgE ELISA
Serum samples were obtained from five J. ashei allergic patients in Austin, Texas, USA. Subjects were selected on the basis of clinical history, positive scratch test to J. ashei and positive ImmunoCAP to native Jun a 3 (Phadia, Uppsala, Sweden). Normal control serum samples were obtained from subjects without clinical allergy history and negative scratch test to J. ashei and dust mite.
Microtiter plates were coated with 100 ll extract that contained 1, 5, or 10 lg/ml of rJun a 3. After blocking with 5% (v/v) non-fat dry milk, 100 ll pooled sera from patients allergic to J. ashei (1:10) or non-allergic individuals was added to each well and incubated at room temperature for 2 h. Bound IgE was detected by adding 100 ll anti-human IgE-HRP conjugate (1:5,000) (Sigma) and incubating at room temperature for 1 h. Colorimetric substrate, TMB, was added and incubated for 1 h at room temperature. The reaction was stopped by adding 100 ll 2 M HCl and the OD 450 nm was measured.
Results
Expression and identification rJun a 3 in N. benthamiana plants The Jun a 3 coding sequence, including its signal peptide, was successfully inserted into the pBSG1057 vector under the control of the TMV-U1 coat protein subgenomic promoter. Insertion of the gene, as well as correct orientation were verified with PCR and DNA sequencing. This construct was used to generate infectious viral RNA, which was subsequently used to inoculate N. benthamiana plants. Ten days post-inoculation, signs of infection, such as mottled and deformed leaves, were apparent not only in locally inoculated leaves but in systemic leaves as well. RT-PCR products confirmed that the Jun a 3 sequence was stably maintained in the TMV vector. SDS-PAGE revealed a band migrating at 30 kDa from the leaves of plants inoculated with vector carrying Jun a 3, which was not present in the control plants (Fig. 1b) . The recombinant proteins were expressed at approx 300 lg from the vacuum infiltrate of 1 g of intact leaves. Western blotting confirmed the identity of the 30 kDa band by its reactivity with an anti-Jun a 3 antiserum (Fig. 2) . N-Terminal sequencing of this band revealed that the signal sequence of the rJun a 3 was correctly processed by the plant. Passage of the virus from an infected leaf to larger, uninoculated plants (second passage) resulted in infection of the larger plants. RT-PCR revealed that stable Jun a 3 RNA transcripts were generated, and SDS-PAGE showed rJun a 3 was expressed in these second passage plants. ELISA experiments demonstrated that IgE antibodies from sera of subjects with J. ashei pollinosis bound to the rJun a 3 from the proteins extracted by vacuum infiltration. The amount of IgE that bound to wells was proportional to the concentration of the rJun a 3 in the coating solution. IgE in the sera from non-allergic individuals did not bind to rJun a 3 (Fig. 3) .
Expression of rJun a 3 in P. pastoris SDS-PAGE analysis of supernatants collected 24 h after induction with methanol revealed a band that approximated the migration of native Jun a 3, which was not seen in the vector control (Fig. 1c) . The highest expression levels were seen at 96 h, when rJun a 3 was expressed at approx 100 lg/ml. Western blot analysis revealed the recombinant protein bound polyclonal antibodies to Jun a 3. ELISA experiments showed that the rJun a 3 displayed was also recognized by the IgE in the patient sera, as indicated by a significant increase in IgE binding relative to wells containing sera from nonallergic individuals. Supernatants from yeast transformed with the same vector lacking the Jun a 3 insert bound less of the IgE from patient sera. In addition, IgE in the sera from non-allergic individuals did not significantly bind rJun a 3 (data not shown). 
Discussion
This study describes the successful expression of a major J. ashei allergen, Jun a 3, in both a virus-mediated plant expression system and a yeast expression system. Both systems are, essentially, secretion expression systems, with the expressed protein being secreted either into the growth medium with yeast or into the intercellular spaces of the apoplast with the plant system. However, the media from the Pichia system contained a larger amount of contaminating proteins. In contrast, the fluid from the vacuum infiltration of the plant expression system yielded a protein product that was approximately 80% pure, which would expedite final purification. This is the first report of apoplastic extraction of a recombinant allergen. Previously expressed recombinant allergens (Krebitz et al. 2000 (Krebitz et al. , 2003 have been extracted by grinding leaves in an extraction buffer. Upon using this extraction method for rJun a 3, several contaminating proteins were extracted as well, making vacuum infiltration a much more valuable tool for extraction from plants (Fig. 1a, b) .
The molecular farming strategy is easy to use, relatively inexpensive, and capable of large-scale production. Additionally, because many allergens are of plant origin, plant-based systems provide a means of homologous expression, particularly because of the plant's ability to process the allergen such that it is very similar to the native allergen. Transient expression vectors can also express larger proteins, with the maximum size of an insert at 1.5 kb for a systemically moving TMV vector (G. Pogue, pers. commun.).
There is a great need for recombinant allergens that mimic the native allergens, not only for structural and mutational analysis, but also to develop vaccines for allergy therapy. Recombinant allergens would allow immunotherapy to be performed with pure allergens as opposed to the crude extracts of plant materials (usually pollens) currently in use. This would allow the injections to be standardized such that the exact amount of allergen would be present from batch to batch. Plant and yeast-based expression systems can provide high quantities of soluble, immunogenic recombinant proteins, which can be hard to obtain with other expression systems such as E. coli. These systems also provide a means of expressing biologically active allergens at low costs. Fig. 3 ELISA showing reactivity of IgE from allergic patient sera with rJun a 3 expressed in N. benthamiana. ELISA plates were coated with vacuum extracts containing varying amount of rJun a 3 and developed with sera from either allergic or nonallergic subjects and anti-human IgE antibody
